|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yeh k h"
Showing items 411-420 of 753 (76 Page(s) Totally)
<< < 37 38 39 40 41 42 43 44 45 46 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-01-12T12:49:20Z |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; SHANG-YI HUANG; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-06T03:59:07Z |
Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome
|
Yeh K.H.; Hsieh H.C.; JIH-LUH TANG; Lin M.T.; Yang C.H.; Chen Y.C. |
| 臺大學術典藏 |
2021-01-06T03:59:02Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; JIH-LUH TANG; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:57Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Cheng A.-L.; Kuo S.-H.; Yeh Y.-C.; Wang H.-P.; Wang Y.-T.; Lin C.-W.; JIH-LUH TANG; Yao M.; Yeh K.-H.; Ma W.-L. |
| 臺大學術典藏 |
2021-01-05T03:34:26Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Wang Y.-T.; Lin C.-W.; Tang J.-L.; MING YAO; Yeh K.-H.; Ma W.-L.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-04T12:13:12Z |
Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy
|
Yeh K.H.; Cheng A.L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:13:04Z |
Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma
|
Liu M.-Y.; Cheng A.-L.; Hsu C.-H.; Wang C.-H.; Tang J.-L.; Yeh K.-H.; Kao W.-Y.; Huang M.-C.; Chang M.-C.; HWEI-FANG TIEN; Chao T.-Y.; Lin Z.-Z.; Su I.-J.; Huang C.-L. |
| 國立成功大學 |
2021 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
|
Yoshino, T.;Argil�s, G.;Oki, E.;Martinelli, E.;Taniguchi, H.;Arnold, D.;Mishima, S.;Li, Y.;Smruti, B.K.;Ahn, J.B.;Faud, I.;Chee, Chee C.E.;Yeh, K.-H.;Lin, P.-C.;Chua, Chua C.;Hasbullah, Hasbullah H.H.;Lee, M.A.;Sharma, A.;Sun, Y.;Curigliano, G.;Bando, H.;Lordick, F.;Yamanaka, T.;Tabernero, J.;Baba, E.;Cervantes, A.;Ohtsu, A.;Peters, S.;Ishioka, C.;Pentheroudakis, G. |
| 國立成功大學 |
2021 |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Yeh, K.-H.;Yang, T.-S.;Hsu, T.-C.;Tzu-Liang, Chen W.;Chen, H.-H.;Teng, H.-W.;Lin, B.-W.;Kuan, F.-C.;Chiang, F.-F.;Duann, C.-W.;Li, Y.-S.;Lin, M.-T.;Fiala-Buskies, S.;Ducreux, M.;Wang, J.-Y. |
Showing items 411-420 of 753 (76 Page(s) Totally)
<< < 37 38 39 40 41 42 43 44 45 46 > >>
View [10|25|50] records per page
|
